World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
106
Citations
37614
World Ranking
569
National Ranking
339

Medicine

D-Index
106
Citations
37616
World Ranking
6588
National Ranking
3498

Thomas W. Geisbert publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Thomas W. Geisbert sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 339 publications — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Thomas W. Geisbert D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas W. Geisbert sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 106 D-Index — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Thomas W. Geisbert is affiliated with The University of Texas Medical Branch at Galveston in the United States. Their research contributions predominantly fall within the field of Medicine, with a specialized focus on Infectious Diseases. Other subfields covered by their work include Epidemiology, Molecular Biology, Modeling and Simulation, and Public Health, Environmental and Occupational Health.

Geisbert's research extensively addresses topics related to viral infections and outbreaks, including viral infections and vectors, SARS-CoV-2 and COVID-19 research, hepatitis B virus studies, virology and viral diseases, viral gastroenteritis research and epidemiology, and COVID-19 epidemiological studies.

Frequent publication venues for their work include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Journal of Infectious Diseases
  • Journal of Virology
  • Science Translational Medicine
  • Cell Reports

Frequent co-authors collaborating with Geisbert are:

  • Robert W. Cross
  • Viktoriya Borisevich
  • Krystle N. Agans
  • Karla A. Fenton
  • Courtney Woolsey

Some recent papers authored by Geisbert include:

  • The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates (2021), published in Science Translational Medicine
  • LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants (2022), published in Cell Reports
  • Establishment of an African green monkey model for COVID-19 and protection against re-infection (2020), published in Nature Immunology
  • Ebola (2020), published in New England Journal of Medicine
  • LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection (2020), published in bioRxiv (Cold Spring Harbor Laboratory)

Best Publications

  • Ebola haemorrhagic fever

    Heinz Feldmann;Heinz Feldmann;Thomas W Geisbert

  • Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.

    Steven M. Jones;Heinz Feldmann;Heinz Feldmann;Ute Ströher;Ute Ströher;Joan B. Geisbert

  • A Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic Fever

    Mike Bray;Kelly Davis;Thomas Geisbert;Connie Schmaljohn

  • Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection.

    Thomas W. Geisbert;Lisa E. Hensley;Tom Larsen;Howard A. Young

  • LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

    Unknown

  • Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

    Nancy J. Sullivan;Thomas W. Geisbert;Joan B. Geisbert;Ling Xu

  • Exotic emerging viral diseases: progress and challenges

    Thomas W Geisbert;Peter B Jahrling

  • Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations.

    Jens H. Kuhn;Stephan Becker;Hideki Ebihara;Thomas W. Geisbert

  • Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study

    Thomas W. Geisbert;Amy Ch Lee;Marjorie Robbins;Joan B. Geisbert

  • Lipid Raft Microdomains A Gateway for Compartmentalized Trafficking of Ebola and Marburg Viruses

    Sina Bavari;Catharine M. Bosio;Elizabeth Wiegand;Gordon Ruthel

  • Pathology of Fatal West Nile Virus Infections in Native and Exotic Birds during the 1999 Outbreak in New York City, New York

    K. E. Steele;M. J. Linn;R. J. Schoepp;N. Komar

  • Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys.

    Thomas W Geisbert;Lisa E Hensley;Peter B Jahrling;Tom Larsen

  • Preliminary report: isolation of Ebola virus from monkeys imported to USA.

    P. B. Jahrling;Thomas Geisbert;E. D. Johnson;C. J. Peters

  • An optofluidic nanoplasmonic biosensor for direct detection of live viruses from biological media.

    Ahmet A. Yanik;Min Huang;Osami Kamohara;Alp Artar

  • Mechanisms Underlying Coagulation Abnormalities in Ebola Hemorrhagic Fever: Overexpression of Tissue Factor in Primate Monocytes/Macrophages Is a Key Event

    Thomas W. Geisbert;Howard A. Young;Peter B. Jahrling;Kelly J. Davis

  • Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus

    Boyd Yount;Kristopher M. Curtis;Elizabeth A. Fritz;Lisa E. Hensley

  • Pathogenesis of Experimental Ebola Virus Infection in Guinea Pigs

    Brett M. Connolly;Keith E. Steele;Kelly J. Davis;Thomas W. Geisbert

  • Pathogenesis of Ebola Hemorrhagic Fever in Primate Models: Evidence that Hemorrhage Is Not a Direct Effect of Virus-Induced Cytolysis of Endothelial Cells

    Thomas W. Geisbert;Howard A. Young;Peter B. Jahrling;Kelly J. Davis

  • The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates.

    Bryan E. Jones;Patricia L. Brown-Augsburger;Kizzmekia S. Corbett;Kathryn Westendorf

  • Evaluation of Immune Globulin and Recombinant Interferon-α2b for Treatment of Experimental Ebola Virus Infections

    Peter B. Jahrling;Peter B. Jahrling;Peter B. Jahrling;Thomas Geisbert;Thomas Geisbert;J. B. Geisbert;J. B. Geisbert;J. R. Swearengen;J. R. Swearengen

  • Differentiation of filoviruses by electron microscopy

    Thomas Geisbert;P. B. Jahrling

  • Panmicrobial oligonucleotide array for diagnosis of infectious diseases.

    Gustavo F. Palacios;Phuong-Lan Quan;Omar J. Jabado;Sean Conlan

Frequent Co-Authors

Joan B. Geisbert
Joan B. Geisbert The University of Texas Medical Branch at Galveston
Heinz Feldmann
Heinz Feldmann National Institutes of Health
Robert W. Cross
Robert W. Cross Galveston College
Lisa E. Hensley
Lisa E. Hensley National Institutes of Health
Peter B. Jahrling
Peter B. Jahrling National Institutes of Health
Peter B. Jahrling
Peter B. Jahrling National Institute of Allergy and Infectious Diseases
Steven M. Jones
Steven M. Jones University of Saskatchewan
Friederike Feldmann
Friederike Feldmann National Institutes of Health
Erica Ollmann Saphire
Erica Ollmann Saphire La Jolla Institute For Allergy & Immunology
Christopher C. Broder
Christopher C. Broder Uniformed Services University of the Health Sciences

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in immunology opens doors to a variety of interdisciplinary healthcare roles. Many professionals complement their immunology expertise by advancing into nursing specialties. For those interested in mental health, exploring the cheapest pmhnp programs online can be a cost-effective way to specialize as a psychiatric mental health nurse practitioner.

Nurse practitioners with a Doctor of Nursing Practice (DNP) degree often see significant career and salary growth. Understanding the dnp salary landscape is essential when planning your educational investments and choosing your work location.

For those aiming to shift focus within nursing, an fnp to acnp bridge program online offers a flexible path to transition from Family Nurse Practitioner to Acute Care Nurse Practitioner, often complementing immunology knowledge with acute care skills.

Lastly, accelerated programs are available for those looking to fast-track their careers. Exploring the accelerated np programs online can provide rapid entry into nurse practitioner roles, blending clinical skills with a strong foundation in immunology-related healthcare.

Best Scientists Citing Thomas W. Geisbert

Trending Scientists

Recently Published Articles